share_log

Zebra Technologies Analyst Ratings

Zebra Technologies Analyst Ratings

斑馬科技分析師評級
Benzinga ·  2023/09/20 05:18
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/20/2023 -12.76% Morgan Stanley $260 → $220 Downgrades Equal-Weight → Underweight
09/05/2023 15% TD Cowen $270 → $290 Maintains Outperform
08/03/2023 7.07% TD Cowen $350 → $270 Maintains Outperform
08/02/2023 3.11% Morgan Stanley $295 → $260 Maintains Equal-Weight
08/02/2023 12.23% Baird $322 → $283 Maintains Outperform
08/02/2023 Wolfe Research Upgrades Underperform → Peer Perform
08/02/2023 9.05% Credit Suisse $295 → $275 Maintains Outperform
08/02/2023 13.02% Needham → $285 Reiterates Buy → Buy
06/22/2023 16.98% Credit Suisse → $295 Reiterates Outperform → Outperform
05/11/2023 38.8% TD Cowen $375 → $350 Maintains Outperform
05/03/2023 16.98% Morgan Stanley $305 → $295 Maintains Equal-Weight
05/03/2023 16.98% Credit Suisse $326 → $295 Maintains Outperform
05/03/2023 27.69% Baird $365 → $322 Maintains Outperform
05/03/2023 34.83% Needham $385 → $340 Maintains Buy
04/25/2023 29.28% Credit Suisse $311 → $326 Upgrades Neutral → Outperform
02/23/2023 23.33% Credit Suisse $313 → $311 Maintains Neutral
02/21/2023 58.62% Stephens & Co. $350 → $400 Maintains Overweight
02/17/2023 52.67% Needham $330 → $385 Maintains Buy
02/09/2023 24.12% Credit Suisse $319 → $313 Downgrades Outperform → Neutral
12/20/2022 24.92% Baird $300 → $315 Maintains Outperform
12/13/2022 3.11% Morgan Stanley $225 → $260 Maintains Equal-Weight
12/13/2022 26.5% Credit Suisse → $319 Initiates Coverage On → Outperform
12/01/2022 Wolfe Research Downgrades Peer Perform → Underperform
11/03/2022 76.47% UBS $485 → $445 Maintains Buy
11/02/2022 18.97% Baird $330 → $300 Maintains Outperform
11/02/2022 30.86% Needham $450 → $330 Maintains Buy
10/14/2022 -10.77% Morgan Stanley $335 → $225 Maintains Equal-Weight
08/04/2022 96.3% UBS $510 → $495 Maintains Buy
08/03/2022 98.28% Stephens & Co. $600 → $500 Maintains Overweight
08/03/2022 78.45% Needham $500 → $450 Maintains Buy
05/23/2022 32.85% Morgan Stanley $400 → $335 Upgrades Underweight → Equal-Weight
05/04/2022 74.49% Baird $540 → $440 Maintains Outperform
05/04/2022 98.28% Needham $535 → $500 Maintains Buy
04/14/2022 137.93% UBS $620 → $600 Maintains Buy
04/12/2022 58.62% Morgan Stanley $470 → $400 Maintains Underweight
04/04/2022 98.28% JP Morgan $530 → $500 Upgrades Neutral → Overweight
03/08/2022 112.16% Needham $580 → $535 Maintains Buy
02/11/2022 130% Needham $620 → $580 Maintains Buy
02/08/2022 145.87% Needham $660 → $620 Maintains Buy
11/03/2021 161.73% Needham $600 → $660 Maintains Buy
09/23/2021 143.88% UBS $610 → $615 Maintains Buy
09/13/2021 177.59% Stephens & Co. $600 → $700 Maintains Overweight
08/04/2021 141.9% UBS $560 → $610 Maintains Buy
08/04/2021 122.07% Baird $490 → $560 Maintains Outperform
08/04/2021 137.93% Needham $580 → $600 Maintains Buy
07/13/2021 122.07% UBS → $560 Maintains Buy
07/02/2021 130% Needham $525 → $580 Maintains Buy
05/05/2021 108.19% Needham $515 → $525 Maintains Buy
04/21/2021 62.59% Morgan Stanley $380 → $410 Downgrades Equal-Weight → Underweight
03/23/2021 122.07% Northcoast Research → $560 Upgrades Neutral → Buy
02/19/2021 114.14% UBS $430 → $540 Maintains Buy
02/12/2021 50.69% Morgan Stanley $335 → $380 Maintains Equal-Weight
02/12/2021 104.23% Needham $445 → $515 Maintains Buy
02/03/2021 76.47% Needham $340 → $445 Maintains Buy
12/15/2020 32.85% Morgan Stanley $250 → $335 Maintains Equal-Weight
11/04/2020 -0.86% Morgan Stanley $240 → $250 Maintains Equal-Weight
11/04/2020 34.83% Needham $320 → $340 Maintains Buy
10/16/2020 Stephens & Co. Initiates Coverage On → Overweight
10/13/2020 26.9% Needham $302 → $320 Maintains Buy
07/29/2020 19.76% Needham $295 → $302 Maintains Buy
07/23/2020 -4.83% Morgan Stanley $217 → $240 Maintains Equal-Weight
07/10/2020 16.98% Needham $250 → $295 Maintains Buy
04/30/2020 -0.86% JP Morgan → $250 Downgrades Overweight → Neutral
04/29/2020 -8.79% Baird $202 → $230 Maintains Outperform
04/29/2020 -13.95% Morgan Stanley $203 → $217 Maintains Equal-Weight
03/19/2020 -8.79% Needham $275 → $230 Maintains Buy
03/16/2020 -19.5% Morgan Stanley → $203 Upgrades Underweight → Equal-Weight
03/12/2020 70.52% UBS → $430 Initiates Coverage On → Buy
02/14/2020 3.9% JP Morgan $250 → $262 Upgrades Neutral → Overweight
01/21/2020 9.05% Needham $255 → $275 Maintains Buy
01/08/2020 -13.95% Morgan Stanley → $217 Downgrades Equal-Weight → Underweight
11/20/2019 5.09% Imperial Capital $245 → $265 Maintains Outperform
11/05/2019 JP Morgan Downgrades Overweight → Neutral
10/31/2019 5.09% Imperial Capital $245 → $265 Maintains Outperform
10/30/2019 7.07% Baird $235 → $270 Maintains Outperform
10/30/2019 -13.95% Morgan Stanley $205 → $217 Maintains Equal-Weight
09/16/2019 -18.71% Morgan Stanley $189 → $205 Maintains Equal-Weight
08/27/2019 -8.79% Atlantic Equities → $230 Initiates Coverage On → Overweight
03/07/2019 Berenberg Initiates Coverage On → Buy
11/12/2018 -18.71% Baird $175 → $205 Maintains Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
09/20/2023 -12.76% 摩根士丹利 $260→$220 評級下調 等重→減碼
09/05/2023 15% TD Cowen $270→$290 維護 跑贏大盤
08/03/2023 7.07% TD Cowen $350→$270 維護 跑贏大盤
08/02/2023 3.11% 摩根士丹利 $295→$260 維護 等重
08/02/2023 12.23% 貝爾德 $322→$283 維護 跑贏大盤
08/02/2023 - 沃爾夫研究 升級 表現不佳的→對等設備
08/02/2023 9.05% 瑞士信貸 $295→$275 維護 跑贏大盤
08/02/2023 13.02% 李約瑟 →$285 重申 購買→購買
2023/06/22 16.98% 瑞士信貸 →$295 重申 跑贏→跑贏大盤
2023年05月11日 38.8% TD Cowen $375→$350 維護 跑贏大盤
05/03/2023 16.98% 摩根士丹利 $305→$295 維護 等重
05/03/2023 16.98% 瑞士信貸 $326→$295 維護 跑贏大盤
05/03/2023 27.69% 貝爾德 $365→$322 維護 跑贏大盤
05/03/2023 34.83% 李約瑟 $385→$340 維護
04/25/2023 29.28% 瑞士信貸 $311→$326 升級 中性→表現優異
02/23/2023 23.33% 瑞士信貸 $313→$311 維護 中性
02/21/2023 58.62% 斯蒂芬斯公司 $350→$400 維護 超重
02/17/2023 52.67% 李約瑟 $330→$385 維護
02/09/2023 24.12% 瑞士信貸 $319→$313 評級下調 跑贏→中性
12/20/2022 24.92% 貝爾德 $300→$315 維護 跑贏大盤
2022年12月13日 3.11% 摩根士丹利 $225→$260 維護 等重
2022年12月13日 26.5% 瑞士信貸 →$319 開始承保 →跑贏大盤
12/01/2022 - 沃爾夫研究 評級下調 同行執行→表現不佳
11/03/2022 76.47% 瑞銀集團 $485→$445 維護
11/02/2022 18.97% 貝爾德 $330→$300 維護 跑贏大盤
11/02/2022 30.86% 李約瑟 $450→$330 維護
10/14/2022 -10.77% 摩根士丹利 $335→$225 維護 等重
08/04/2022 96.3% 瑞銀集團 $510→$495 維護
08/03/2022 98.28% 斯蒂芬斯公司 $600→$500 維護 超重
08/03/2022 78.45% 李約瑟 $500→$450 維護
2022年05月23日 32.85% 摩根士丹利 $400→$335 升級 重量不足的→等重
05/04/2022 74.49% 貝爾德 $540→$440 維護 跑贏大盤
05/04/2022 98.28% 李約瑟 $535→$500 維護
04/14/2022 137.93% 瑞銀集團 $620→$600 維護
04/12/2022 58.62% 摩根士丹利 $470→$400 維護 體重不足
04/04/2022 98.28% 摩根大通 $530→$500 升級 中性→超重
03/08/2022 112.16% 李約瑟 $580→$535 維護
02/11/2022 130% 李約瑟 $620→$580 維護
02/08/2022 145.87% 李約瑟 $660→$620 維護
11/03/2021 161.73% 李約瑟 $600→$660 維護
09/23/2021 143.88% 瑞銀集團 $610→$615 維護
09/13/2021 177.59% 斯蒂芬斯公司 $600→$700 維護 超重
08/04/2021 141.9% 瑞銀集團 $560→$610 維護
08/04/2021 122.07% 貝爾德 $490→$560 維護 跑贏大盤
08/04/2021 137.93% 李約瑟 $580→$600 維護
07/13/2021 122.07% 瑞銀集團 →$560 維護
07/02/2021 130% 李約瑟 $525→$580 維護
05/05/2021 108.19% 李約瑟 $515→$525 維護
04/21/2021 62.59% 摩根士丹利 $380→$410 評級下調 等重→減碼
03/23/2021 122.07% 北岸研究 →$560 升級 中性→購買
02/19/2021 114.14% 瑞銀集團 $430→$540 維護
02/12/2021 50.69% 摩根士丹利 $335→$380 維護 等重
02/12/2021 104.23% 李約瑟 $445→$515 維護
02/03/2021 76.47% 李約瑟 $340→$445 維護
12/15/2020 32.85% 摩根士丹利 $250→$335 維護 等重
11/04/2020 -0.86% 摩根士丹利 $240→$250 維護 等重
11/04/2020 34.83% 李約瑟 $320→$340 維護
10/16/2020 - 斯蒂芬斯公司 開始承保 →超重
10/13/2020 26.9% 李約瑟 $302→$320 維護
07/29/2020 19.76% 李約瑟 $295→$302 維護
07/23/2020 -4.83% 摩根士丹利 $217→$240 維護 等重
07/10/2020 16.98% 李約瑟 $250→$295 維護
04/30/2020 -0.86% 摩根大通 →$250 評級下調 超重→中性
04/29/2020 -8.79% 貝爾德 $202→$230 維護 跑贏大盤
04/29/2020 -13.95% 摩根士丹利 $203→$217 維護 等重
3/19/2020 -8.79% 李約瑟 $275→$230 維護
03/16/2020 -19.5% 摩根士丹利 →$203 升級 重量不足的→等重
03/12/2020 70.52% 瑞銀集團 →$430 開始承保 →購買
02/14/2020 3.9% 摩根大通 $250→$262 升級 中性→超重
2020/01/21 9.05% 李約瑟 $255→$275 維護
1/08/2020 -13.95% 摩根士丹利 →$217 評級下調 等重→減碼
2019年11月20日 5.09% 帝都 $245→$265 維護 跑贏大盤
2019年11月05日 - 摩根大通 評級下調 超重→中性
2019年10月31日 5.09% 帝都 $245→$265 維護 跑贏大盤
2019年10月30日 7.07% 貝爾德 $235→$270 維護 跑贏大盤
2019年10月30日 -13.95% 摩根士丹利 $205→$217 維護 等重
2019/09/16 -18.71% 摩根士丹利 $189→$205 維護 等重
2019年08月27日 -8.79% 大西洋證券公司 →$230 開始承保 →超重
2019年07月03日 - 貝倫伯格 開始承保 →購買
2018年11月12日 -18.71% 貝爾德 $175→$205 維護 跑贏大盤

What is the target price for Zebra Technologies (ZBRA)?

斑馬科技(Zebra Technologies)的目標價是多少?

The latest price target for Zebra Technologies (NASDAQ: ZBRA) was reported by Morgan Stanley on September 20, 2023. The analyst firm set a price target for $220.00 expecting ZBRA to fall to within 12 months (a possible -12.76% downside). 27 analyst firms have reported ratings in the last year.

斑馬科技(納斯達克:ZBRA)的最新目標價是摩根士丹利在2023年9月20日報道的。這家分析公司將目標價定為220.00美元,預計ZBRA將在12個月內降至(可能下跌12.76%)。去年有27家分析公司公佈了評級。

What is the most recent analyst rating for Zebra Technologies (ZBRA)?

斑馬科技(ZBRA)最新的分析師評級是多少?

The latest analyst rating for Zebra Technologies (NASDAQ: ZBRA) was provided by Morgan Stanley, and Zebra Technologies downgraded their underweight rating.

斑馬科技(納斯達克:ZBRA)的最新分析師評級由摩根士丹利提供,斑馬科技下調了其減持評級。

When is the next analyst rating going to be posted or updated for Zebra Technologies (ZBRA)?

斑馬科技(ZBRA)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zebra Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zebra Technologies was filed on September 20, 2023 so you should expect the next rating to be made available sometime around September 20, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與斑馬科技的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。斑馬技術的上一次評級是在2023年9月20日提交的,所以你應該預計下一次評級將在2024年9月20日左右的某個時候公佈。

Is the Analyst Rating Zebra Technologies (ZBRA) correct?

分析師對斑馬科技(ZBRA)的評級正確嗎?

While ratings are subjective and will change, the latest Zebra Technologies (ZBRA) rating was a downgraded with a price target of $260.00 to $220.00. The current price Zebra Technologies (ZBRA) is trading at is $252.17, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的斑馬科技(Zebra Technologies)評級被下調,目標價為260.00美元至220.00美元。斑馬科技目前的交易價格為252.17美元,超出了分析師的預測範圍。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論